Cite
AD Hyper-IgE Syndrome Due to a Novel Loss-of-Function Mutation in STAT3: a Diagnostic Pursuit Won by Clinical Acuity.
MLA
Moens, Leen, et al. “AD Hyper-IgE Syndrome Due to a Novel Loss-of-Function Mutation in STAT3: A Diagnostic Pursuit Won by Clinical Acuity.” Journal of Clinical Immunology, vol. 37, no. 1, Jan. 2017, pp. 12–17. EBSCOhost, https://doi.org/10.1007/s10875-016-0351-9.
APA
Moens, L., Schaballie, H., Bosch, B., Voet, A., Bossuyt, X., Casanova, J.-L., Boisson-Dupuis, S., Tangye, S., & Meyts, I. (2017). AD Hyper-IgE Syndrome Due to a Novel Loss-of-Function Mutation in STAT3: a Diagnostic Pursuit Won by Clinical Acuity. Journal of Clinical Immunology, 37(1), 12–17. https://doi.org/10.1007/s10875-016-0351-9
Chicago
Moens, Leen, Heidi Schaballie, Barbara Bosch, Arnout Voet, Xavier Bossuyt, Jean-Laurent Casanova, Stephanie Boisson-Dupuis, Stuart Tangye, and Isabelle Meyts. 2017. “AD Hyper-IgE Syndrome Due to a Novel Loss-of-Function Mutation in STAT3: A Diagnostic Pursuit Won by Clinical Acuity.” Journal of Clinical Immunology 37 (1): 12–17. doi:10.1007/s10875-016-0351-9.